Product Information
FONDAPARINUX 10 MG/0.8 ML SYR is a generic product labeled by Mylan Institutional LLC, priced at $44.8161 per ML under NDC 67457058508. Its NADAC has been published 220 times since Jul 20, 2022.
FDA first approved this application on Dec 7, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/.8mL
Manufacturer
Mylan Institutional LLCNDC
67457058508
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021345FDA Approved
12/7/2001
TE Code
AP
On Market Since
1/5/2015
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has been published 220 times since Jul 20, 2022, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.8161 per ML |
|---|---|
| All-time high | $53.5408 (May 15, 2024) |
| All-time low | $29.5253 (May 21, 2025) |
| 52-week high | $46.2815 |
| 52-week low | $31.8179 |
| Median price | $45.0801 |
| Average price | $43.2371 |
| Largest weekly change | -26.6% (May 22, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fondaparinux sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 10 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 10 MG/0.8 ML SYR, manufactured by Mylan Institutional LLC, is $44.8161 per ML (NDC 67457058508), effective Sep 30, 2026.
How has the price of FONDAPARINUX 10 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has declined 10.5%. It has been tracked across 220 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 10 MG/0.8 ML SYR?
Since Jul 20, 2022, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has ranged from a low of $29.5253 (May 21, 2025) to a high of $53.5408 (May 15, 2024), with a median of $45.0801 per ML.
Are there cheaper alternatives to FONDAPARINUX 10 MG/0.8 ML SYR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 10 MG/0.8 ML SYR, is $18.3687 per ML — about 59% below FONDAPARINUX 10 MG/0.8 ML SYR.
Who manufactures FONDAPARINUX 10 MG/0.8 ML SYR?
FONDAPARINUX 10 MG/0.8 ML SYR (NDC 67457058508) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.